---  
layout: startup_page  
title: "RevOpsis Therapeutics"  
id: "revopsis.com"  
permalink: "/revopsistherapeuticsrevopsis.com04252024/"  
website: "https://www.revopsis.com/"  
funding_round: "Seed"  
funding_amount: "$16.5M"  
investors: "a leading contract development and manufacturing organization (CDMO) with global commercial drug supply capabilities, an ophthalmic drug and device development firm, and various private and angel investors, including several leading retina specialists"  
about: "RevOpsis Therapeutics is a biopharmaceutical company focused on developing and commercializing treatments for chronic multifactorial diseases. They utilize their proprietary Rev-Mod Platform to create multispecific biologics, with their lead candidate, RO-104, targeting neovascular age-related macular degeneration (nAMD). The company aims to improve visual outcomes and extend disease remission for patients."  
markets: "Biotechnology, Pharmaceuticals, Ophthalmology"  
hq: "Springfield, Illinois, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/revopsis"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/revopsis-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/532885-06"  

date_display: "25-Apr-2024"  
date: "2024-04-25"

# SEO Optimization  
meta_title: "RevOpsis Therapeutics - Seed Funding ($16.5M)"  
meta_description: "RevOpsis Therapeutics, RevOpsis Therapeutics is a biopharmaceutical company focused on developing and commercializing treatments for chronic multifactorial diseases. They ut..."  
meta_keywords: "RevOpsis Therapeutics, Biotechnology, Pharmaceuticals, Ophthalmology, Seed funding"  
canonical_url: "https://startup.projectstartups.com/revopsistherapeuticsrevopsis.com04252024/"  
---